Huang, Hongfeng <br/><br/>
Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients.  [electronic resource] 

 -  Transplant infectious disease : an official journal of the Transplantation Society  Feb 2019 
 - e13018 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1399-3062 
<br/><br/><label>Standard No.: </label>10.1111/tid.13018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Carbamates<br/>Drug Therapy, Combination--methods<br/>Female<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Imidazoles--therapeutic use<br/>Kidney Transplantation--adverse effects<br/>Liver--physiopathology<br/>Liver Function Tests<br/>Male<br/>Middle Aged<br/>Pyrrolidines<br/>Retrospective Studies<br/>Sofosbuvir--therapeutic use<br/>Sustained Virologic Response<br/>Transplant Recipients<br/>Treatment Outcome<br/>Valine--analogs & derivatives<br/>Viral Load